Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2022 / Oct / The Architecture of ADHD
Neurology Genetics and epigenetics Neurology Molecular Pathology

The Architecture of ADHD

Do ADHD subgroups stem from different genetic etiologies?

By Liv Gaskill 10/24/2022 News 2 min read

Share

ADHD is a childhood-onset neurodevelopmental disorder that can persist into the adult years. However, according to the ICD-10 and DSM-5 diagnostic criteria, although behavioral symptoms must have been present before six or 12 years of age, the condition can be diagnosed later in life (late-diagnosed ADHD). Affecting around 6 percent of school-age children and about 3 percent of adults, risk factors for ADHD are a complex issue, with both environmental and genetic factors playing a role.

Given the condition’s complex nature, might childhood, persistent, and late-diagnosed ADHD stem from different etiologies? To find out, an international team of researchers conducted a genome-wide association study for each subgroup to understand whether there are genetic differences between them (1).

For childhood ADHD, the study revealed four genome-wide significant loci on chromosomes 1, 5, 18, and 20. The risk loci on chromosomes 1 and 5 were already known, but those on chromosomes 18 and 20 were new. Analysis of late-diagnosed ADHD revealed one significant locus on chromosome 7, but none were found for persistent ADHD – an expected outcome given the low number of cases in this group. When measuring genetic overlap with ADHD symptoms in the general population, the team found that measures of hyperactivity and inattention were highly correlated with childhood and persistent ADHD, but less so with late-diagnosed ADHD.

People with ADHD sometimes have comorbid psychiatric disorders; to understand whether this might be linked with differences in genetic architecture, the team performed genetic correlation and polygenic score analyses for major psychiatric disorders. They found positive genetic correlations between ADHD subgroups and schizophrenia, bipolar disorder, autism, major depressive disorder, cannabis use disorder, and alcohol use disorder, as well as negative correlations with anorexia and obsessive-compulsive disorder. Childhood ADHD had greater genetic overlap with autism than late-diagnosed ADHD; the latter had a higher overlap with depression.

Overall, the findings demonstrate the impact of genetic heterogeneity of ADHD on age at first diagnosis, persistence, and comorbidity patterns across subgroups.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. VM Rajagopal et al., Nat Genet, 54, 1117 (2022). PMID: 35927488.

About the Author(s)

Liv Gaskill

During my undergraduate degree in psychology and Master’s in neuroimaging for clinical and cognitive neuroscience, I realized the tasks my classmates found tedious – writing essays, editing, proofreading – were the ones that gave me the greatest satisfaction. I quickly gathered that rambling on about science in the bar wasn’t exactly riveting for my non-scientist friends, so my thoughts turned to a career in science writing. At Texere, I get to craft science into stories, interact with international experts, and engage with readers who love science just as much as I do.

More Articles by Liv Gaskill

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Breathing New Life into Diagnostics
Genetics and epigenetics
Breathing New Life into Diagnostics

January 22, 2024

6 min read

Jonathan Edgeworth on how metagenomics could transform testing for respiratory infections

Molecular Spectacular
Genetics and epigenetics
Molecular Spectacular

January 8, 2024

1 min read

A look at last year’s most interesting molecular pathology stories

Redefining Diagnostic Reference Standards
Genetics and epigenetics
Redefining Diagnostic Reference Standards

January 3, 2022

1 min read

Find out what Horizon Discovery’s diagnostic reference standards can do for your workflow

Defining the Next Generation of NGS
Genetics and epigenetics
Defining the Next Generation of NGS

December 31, 2021

1 min read

Overcoming challenges of the typical NGS workflow with the Ion Torrent™ Genexus™ System

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.